• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.03% Nasdaq Up 0.29%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    56.56 1.89(3.46%) Jan 26, 4:00PM EST
    Add to Portfolio
    Prev Close:54.67
    Open:54.48
    Bid:N/A
    Ask:57.00 x 100
    1y Target Est:84.80
    Beta:1.85
    Earnings Date:Feb 9 - Feb 13 (Est.)
    Day's Range:54.28 - 56.65
    52wk Range:41.99 - 80.42
    Volume:233,461
    Avg Vol (3m):283,650
    Market Cap:1.13B
    P/E (ttm):171.39
    EPS (ttm):0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for LGND

    Comparison

    Symbol% ChgMkt Cap
    LGNDUp 3.46%1.13B
    LLY77.13B
    MRK179.09B
    RHHBYN/A

    Key Statistics

    Forward P/E (1 yr):24.59
    P/S (ttm):19.45
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-14) :1.53
    Quarterly EPS Est (Dec-14) :0.60
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):0.76

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback